lifestyle.marketresearchjournals.com

Author: WIRE NEWS NETWORK

FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month

February 17, 2026
Blue Diamond Growers Introduces New Line: Blue Diamond Almondmilk

February 14, 2026
ByzFunder Reports 40% Growth in 2025, Driven by AI Underwriting, ByzFlex Expansion, and a 30% Increase in Customer Portal Engagement

February 12, 2026
RSM Names Joseph Taiano Chief Marketing Officer as the Firm Redefines the Middle Market and Accelerates Global Platform

February 12, 2026
FOSSIL GROUP, INC. APPOINTS SHANNON FREEZE AS CHIEF PEOPLE AND COMMUNICATIONS OFFICER

February 12, 2026
RSM Redefines the Middle Market to Reflect Structural Modernization and Rising Complexity

February 10, 2026
Scouting America Launches Impact365 to Mobilize Youth Service Nationwide

February 10, 2026
From the Founders of Fitbit: Introducing Luffu, Your Guardian for Family Health & Safety

February 3, 2026
Scratch Made with Love: Hardee’s® Heart Shaped Biscuits Return for Valentine’s Day with New Iced Coffee

February 2, 2026
Real-world head-to-head analysis shows 51% reduction in risk of death for patients with metastatic castration-sensitive prostate cancer treated with ERLEADA® (apalutamide) versus darolutamide without docetaxel through 24 months

February 2, 2026